Dorina Avram

5PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursInnate immunityEpigenetics (incl. genome methylation and epigenomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 15, 2026
BCL11B targeting in tumor CD8 + T cells amplifies anti-tumor response by blocking exhaustion while promoting stemness and cytotoxicity.

|Aug 24, 2023
Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer.

Yang Feng, Qingchen Yuan, Rachel C Newsome

|Apr 28, 2023
Bcl11b sustains multipotency and restricts effector programs of intestinal-resident memory CD8+ T cells.

Eric Y Helm, Tomas Zelenka, Valeriu B Cismasiu

|Mar 13, 2021
The transcription factor Bcl11b promotes both canonical and adaptive NK cell differentiation.

Tim D Holmes, Ram Vinay Pandey, Eric Y Helm

|Aug 29, 2019
Bcl11b prevents fatal autoimmunity by promoting Treg cell program and constraining innate lineages in Treg cells.

Theodore T Drashansky, Eric Helm, Zhiguang Huo

Pageof 1

Frequent Collaborators

3 joint publications

Eric Y Helm

2 joint publications

Theodore T Drashansky

2 joint publications

Zhiguang Huo

2 joint publications

Ashley Zuniga